Compare · AMRS vs SOLS
AMRS vs SOLS
Side-by-side comparison of Amyris Inc. (AMRS) and Solstice Advanced Materials Inc. (SOLS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AMRS and SOLS operate in Major Chemicals (Industrials), so they compete in similar markets.
- SOLS carries a market cap of $9.12B.
- SOLS has hit the wire 6 times in the past 4 weeks while AMRS has been quiet.
- Both have 13 recent analyst ratings on file.
- Company
- Amyris Inc.
- Solstice Advanced Materials Inc.
- Price
- -
- -
- Market cap
- -
- $9.12B
- 1M return
- -
- -3.64%
- 1Y return
- -
- +22.31%
- Industry
- Major Chemicals
- Major Chemicals
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2010
- News (4w)
- 0
- 6
- Recent ratings
- 13
- 13
Amyris Inc.
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty markets through its consumer brands and as a supplier of sustainable and natural ingredients in Europe, the United States, Asia, Brazil, and internationally. It manufactures and sells products for the health and wellness, clean beauty, and flavor and fragrance markets. The company operates under the Amyris, Biofene, Biossance, Pipette, Purecane, and No Compromise trademarks. Amyris, Inc. has a collaboration agreement with the Infectious Disease Research Institute to advance a novel ribonucleic acid vaccine platform, including accelerating the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California.
Latest AMRS
- AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary
- Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
- SEC Form S-8 POS filed by Amyris Inc.
- SEC Form S-8 POS filed by Amyris Inc.
- SEC Form S-8 POS filed by Amyris Inc.
- SEC Form S-8 POS filed by Amyris Inc.
- SEC Form POS AM filed by Amyris Inc.
- SEC Form POS AM filed by Amyris Inc.
- SEC Form S-8 POS filed by Amyris Inc.
- SEC Form S-8 POS filed by Amyris Inc.
Latest SOLS
- SEC Form 10-Q filed by Solstice Advanced Materials Inc.
- Solstice Advanced Materials Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Solstice Advanced Materials Reports Third Quarter 2026 Results
- Solstice Advanced Materials Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Solstice Advanced Materials Declares Dividend of $0.075 per Common Share
- Barclays initiated coverage on Solstice Advance Materials with a new price target
- Solstice Announces $49 Million Investment to Expand Research and Development Capabilities in Buffalo, New York
- Seaport Research Partners initiated coverage on Solstice Advance Materials with a new price target
- Solstice Advanced Materials to Announce Third Quarter 2026 Financial Results on November 4, 2026
- SEC Form 4 filed by Director Oplinger William F